797 related articles for article (PubMed ID: 11380491)
21. Second-line tests in the differential diagnosis of ACTH-dependent Cushing's syndrome.
Barbot M; Trementino L; Zilio M; Ceccato F; Albiger N; Daniele A; Frigo AC; Mardari R; Rolma G; Boscaro M; Arnaldi G; Scaroni C
Pituitary; 2016 Oct; 19(5):488-95. PubMed ID: 27236452
[TBL] [Abstract][Full Text] [Related]
22. [Evaluation of the accuracy of inferior petrosal sinus sampling in the differential diagnosis of ACTH-dependent Cushing's syndrome].
Tóth M; Vajda Z; Görömbey Z; Molnár F; Major L; Toke J; Szabolcs I; Szücs N; Kovács L; Kiss R; Czirják S; Füto L; Gláz E; Góth M; Rácz K
Orv Hetil; 2007 May; 148(18):843-7. PubMed ID: 17468067
[TBL] [Abstract][Full Text] [Related]
23. Effectiveness versus efficacy: the limited value in clinical practice of high dose dexamethasone suppression testing in the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome.
Aron DC; Raff H; Findling JW
J Clin Endocrinol Metab; 1997 Jun; 82(6):1780-5. PubMed ID: 9177382
[TBL] [Abstract][Full Text] [Related]
24. Corticotropin-releasing hormone stimulation following low-dose dexamethasone administration. A new test to distinguish Cushing's syndrome from pseudo-Cushing's states.
Yanovski JA; Cutler GB; Chrousos GP; Nieman LK
JAMA; 1993 May; 269(17):2232-8. PubMed ID: 8386285
[TBL] [Abstract][Full Text] [Related]
25. ACTH after 15 min distinguishes between Cushing's disease and ectopic Cushing's syndrome: a proposal for a short and simple CRH test.
Ritzel K; Beuschlein F; Berr C; Osswald A; Reisch N; Bidlingmaier M; Schneider H; Honegger J; Geyer LL; Schopohl J; Reincke M
Eur J Endocrinol; 2015 Aug; 173(2):197-204. PubMed ID: 25953828
[TBL] [Abstract][Full Text] [Related]
26. A very high dose dexamethasone suppression test for differential diagnosis of Cushing's syndrome.
al-Saadi N; Diederich S; Oelkers W
Clin Endocrinol (Oxf); 1998 Jan; 48(1):45-51. PubMed ID: 9509067
[TBL] [Abstract][Full Text] [Related]
27. Non-invasive Diagnostic Strategy in ACTH-dependent Cushing's Syndrome.
Frete C; Corcuff JB; Kuhn E; Salenave S; Gaye D; Young J; Chanson P; Tabarin A
J Clin Endocrinol Metab; 2020 Oct; 105(10):. PubMed ID: 32594169
[TBL] [Abstract][Full Text] [Related]
28. Enhancing Cushing's disease diagnosis: exploring the impact of desmopressin on ACTH gradient during BIPSS.
de Almeida TS; Rodrigues TDC; Costenaro F; Scaffaro LA; Farenzena M; Gastaldo F; Czepielewski MA
Front Endocrinol (Lausanne); 2023; 14():1224001. PubMed ID: 37600715
[TBL] [Abstract][Full Text] [Related]
29. Plasma corticotropin and cortisol responses to ovine corticotropin-releasing hormone (CRH), arginine vasopressin (AVP), CRH plus AVP, and CRH plus metyrapone in patients with Cushing's disease.
Dickstein G; DeBold CR; Gaitan D; DeCherney GS; Jackson RV; Sheldon WR; Nicholson WE; Orth DN
J Clin Endocrinol Metab; 1996 Aug; 81(8):2934-41. PubMed ID: 8768855
[TBL] [Abstract][Full Text] [Related]
30. Desmopressin stimulation test before and after pituitary surgery in patients with Cushing's disease.
Losa M; Mortini P; Dylgjeri S; Barzaghi R; Franzin A; Mandelli C; Giovanelli M
Clin Endocrinol (Oxf); 2001 Jul; 55(1):61-8. PubMed ID: 11453953
[TBL] [Abstract][Full Text] [Related]
31. The ovine corticotropin-releasing hormone (CRH) stimulation test is superior to the human CRH stimulation test for the diagnosis of Cushing's disease.
Nieman LK; Cutler GB; Oldfield EH; Loriaux DL; Chrousos GP
J Clin Endocrinol Metab; 1989 Jul; 69(1):165-9. PubMed ID: 2543689
[TBL] [Abstract][Full Text] [Related]
32. Diagnosis and management of Cushing's syndrome: results of an Italian multicentre study. Study Group of the Italian Society of Endocrinology on the Pathophysiology of the Hypothalamic-Pituitary-Adrenal Axis.
Invitti C; Pecori Giraldi F; de Martin M; Cavagnini F
J Clin Endocrinol Metab; 1999 Feb; 84(2):440-8. PubMed ID: 10022398
[TBL] [Abstract][Full Text] [Related]
33. [The desmopressin test in the diagnosis of Cushing's disease].
Gasińiska T; Dec R; Wichary H; Pietrasik L; Kulawik G
Pol Arch Med Wewn; 2007; 117(1-2):20-6. PubMed ID: 17642202
[TBL] [Abstract][Full Text] [Related]
34. The role of non-invasive dynamic tests in the diagnosis of Cushing's syndrome.
Vilar L; Freitas MC; Naves LA; Canadas V; Albuquerque JL; Botelho CA; Egito CS; Arruda MJ; Silva LM; Arahata CM; Agra R; Lima LH; Azevedo M; Casulari LA
J Endocrinol Invest; 2008 Nov; 31(11):1008-13. PubMed ID: 19169058
[TBL] [Abstract][Full Text] [Related]
35. The ovine corticotropin-releasing hormone stimulation test and the dexamethasone suppression test in the differential diagnosis of Cushing's syndrome.
Nieman LK; Chrousos GP; Oldfield EH; Avgerinos PC; Cutler GB; Loriaux DL
Ann Intern Med; 1986 Dec; 105(6):862-7. PubMed ID: 3022629
[TBL] [Abstract][Full Text] [Related]
36. Discriminatory value of the low-dose dexamethasone suppression test in establishing the diagnosis and differential diagnosis of Cushing's syndrome.
Isidori AM; Kaltsas GA; Mohammed S; Morris DG; Jenkins P; Chew SL; Monson JP; Besser GM; Grossman AB
J Clin Endocrinol Metab; 2003 Nov; 88(11):5299-306. PubMed ID: 14602765
[TBL] [Abstract][Full Text] [Related]
37. Growth hormone and prolactin responses to corticotrophin-releasing-hormone in patients with Cushing's disease: a paracrine action of the adenomatous corticotrophic cells?
Loli P; Boccardi E; Branca V; Bramerio M; Barberis M; Losa M; Terreni MT; Lodrini S; Pollo B; Vignati F
Clin Endocrinol (Oxf); 1998 Oct; 49(4):433-9. PubMed ID: 9876339
[TBL] [Abstract][Full Text] [Related]
38. The corticotropin-releasing factor stimulation test. An aid in the evaluation of patients with Cushing's syndrome.
Chrousos GP; Schulte HM; Oldfield EH; Gold PW; Cutler GB; Loriaux DL
N Engl J Med; 1984 Mar; 310(10):622-6. PubMed ID: 6319991
[TBL] [Abstract][Full Text] [Related]
39. [Difficulties in the diagnosis of Cushing's disease--usefulness of desmopressin test].
Gasińska T; Dec R; Wichary H; Kulawik G
Wiad Lek; 2007; 60(1-2):80-2. PubMed ID: 17607974
[TBL] [Abstract][Full Text] [Related]
40. Plasma corticotrophin response to desmopressin in patients with Cushing's disease correlates with the expression of vasopressin receptor 2, but not with that of vasopressin receptor 1 or 3, in their pituitary tumours.
Wang FF; Tang KT; Yen YS; Ho DM; Yang AH; Huang CI; Lin HD; Won JG
Clin Endocrinol (Oxf); 2012 Feb; 76(2):253-63. PubMed ID: 21781143
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
